HilleVax, Inc. (NASDAQ:HLVX) Director Aditya Kohli Sells 6,000 Shares

HilleVax, Inc. (NASDAQ:HLVX) Director Aditya Kohli sold 6,000 shares of the firm’s stock in a transaction dated Wednesday, May 22nd. The shares were sold at an average price of $14.73, for a total value of $88,380.00. Following the sale, the director now owns 764,878 shares of the company’s stock, valued at $11,266,652.94. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.

Aditya Kohli also recently made the following trade(s):

• On Monday, May 20th, Aditya Kohli sold 6,000 shares of HilleVax stock. The shares were sold at an average price of $15.45, for a total value of $92,700.00.
• On Friday, May 3rd, Aditya Kohli sold 723 shares of HilleVax stock. The shares were sold at an average price of $14.15, for a total value of $10,230.45.
• On Wednesday, May 1st, Aditya Kohli sold 175 shares of HilleVax stock. The stock was sold at an average price of $14.03, for a total transaction of $2,455.25.
• On Friday, April 5th, Aditya Kohli sold 6,000 shares of HilleVax stock. The stock was sold at an average price of $14.44, for a total transaction of $86,640.00.
• On Wednesday, April 3rd, Aditya Kohli sold 6,000 shares of HilleVax stock. The shares were sold at an average price of $14.93, for a total transaction of $89,580.00.
• On Wednesday, March 20th, Aditya Kohli sold 6,000 shares of HilleVax stock. The stock was sold at an average price of $164,221.00, for a total value of $985,326,000.00.
• On Monday, March 18th, Aditya Kohli sold 6,000 shares of HilleVax stock. The shares were sold at an average price of $17.66, for a total value of $105,960.00.
• On Friday, March 8th, Aditya Kohli sold 6,000 shares of HilleVax stock. The stock was sold at an average price of $18.66, for a total value of $111,960.00.
• On Wednesday, March 6th, Aditya Kohli sold 6,000 shares of HilleVax stock. The shares were sold at an average price of $18.95, for a total value of $113,700.00.
• On Thursday, February 22nd, Aditya Kohli sold 6,000 shares of HilleVax stock. The stock was sold at an average price of $15.05, for a total transaction of $90,300.00.

HilleVax Trading Down 2.7 %

Shares of HLVX opened at $14.14 on Thursday. The firm has a fifty day moving average of $14.57 and a 200-day moving average of $14.96. The company has a debt-to-equity ratio of 0.11, a current ratio of 10.92 and a quick ratio of 10.92. HilleVax, Inc. has a 1 year low of $9.94 and a 1 year high of $20.22.

HilleVax (NASDAQ:HLVX) last posted its earnings results on Wednesday, March 20th. The company reported ($0.78) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.80) by $0.02. Equities analysts forecast that HilleVax, Inc. will post -3.14 earnings per share for the current year.

Analyst Ratings Changes

A number of research analysts have recently issued reports on HLVX shares. HC Wainwright restated a “buy” rating and issued a $28.00 price target on shares of HilleVax in a research report on Friday, May 10th. JPMorgan Chase & Co. lifted their target price on HilleVax from $21.00 to $24.00 and gave the company an “overweight” rating in a research note on Wednesday, May 15th.

Institutional Trading of HilleVax

Large investors have recently added to or reduced their stakes in the business. Deerfield Management Company L.P. Series C raised its stake in shares of HilleVax by 20.3% during the third quarter. Deerfield Management Company L.P. Series C now owns 4,004,231 shares of the company’s stock valued at $53,857,000 after purchasing an additional 675,000 shares in the last quarter. Franklin Resources Inc. increased its stake in shares of HilleVax by 4.1% during the fourth quarter. Franklin Resources Inc. now owns 1,846,396 shares of the company’s stock valued at $29,635,000 after acquiring an additional 71,938 shares during the period. Braidwell LP raised its holdings in HilleVax by 16.0% during the third quarter. Braidwell LP now owns 1,449,246 shares of the company’s stock worth $19,492,000 after purchasing an additional 200,000 shares in the last quarter. Catalys Pacific LLC bought a new position in HilleVax during the 4th quarter valued at $21,009,000. Finally, StepStone Group LP raised its stake in shares of HilleVax by 22.2% in the 3rd quarter. StepStone Group LP now owns 826,567 shares of the company’s stock worth $11,117,000 after buying an additional 149,998 shares in the last quarter. 86.42% of the stock is currently owned by institutional investors and hedge funds.

HilleVax Company Profile

HilleVax, Inc, a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. It develops HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company was formerly known as MokshaCo, Inc and changed its name to HilleVax, Inc in February 2021.